MALAN: Biomechanical Reappraisal of Planning for Thoracic Endovascular Aortic Repair

Sponsor
Ospedale San Donato (Other)
Overall Status
Recruiting
CT.gov ID
NCT03824626
Collaborator
University of Pavia (Other)
45
1
32.3
1.4

Study Details

Study Description

Brief Summary

Thoracic endovascular aortic repair (TEVAR) for disease involving the aortic arch remains complex and challenging due the angulation and tortuosity of the arch and its peculiar biomechanical environment. Currently, TEVAR planning is based on the analysis of anatomical features by means of static imaging protocols. Such an approach, however, disregards the impact of pulsatile forces that are transmitted as migration forces on the terminal fixation sites of the endograft, and may jeopardize the long-term clinical success of the procedure. Hence,the investigators aim to assess the migration forces acting on different proximal landing zones of the aortic arch by computational modeling, and develop in silico patient-specific simulations that can provide a quantitative evaluation of the stent-graft performance. Study's results are expected to provide valuable insights for proper proximal landing zone and stent-graft selection during TEVAR planning, and ultimately improve postoperative outcome.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: TEVAR patients

Detailed Description

Hypothesis and Significance: Specific and consistent fluid dynamic patterns and drag forces magnitude and distribution can be identified in the PLZs of the aortic arch providing valuable insights for proper PLZ and stent-graft selection during TEVAR planning.

Specific Aim: 1) To assess the drag forces acting on different PLZs of the aortic arch by means of Computed Fluid Dynamic (CFD) analysis of preoperative phase contrast-Magnetic Resonance (pc-MRI) and Computed Tomography Angiography (CTA) images. The specific goal is to identify the correlation between different magnitude and direction of migration forces and geometrical patterns of the arch to identify suboptimal landing zones for stent-graft deployment. 2) To develop and perform in-silico simulations of the deployment of different commercially available endografts with patient specific boundary conditions. The exact goal is to assess the impact of the mechanical characteristics of a specific device on the vessel wall by structural finite element analysis (FEA), and on the drag forces in different landing zones by CFD, to identify the more suitable endograft. 3) To assess the drag forces exerted postoperatively on the endograft by means of CFD analysis based on follow-up images (i.e., pc-MRI and CTA). The specific goal is to evaluate the predictive value of the drag forces measured preoperatively in the PLZs, and validate the results from in-silico simulations.

Experimental Design Aim 1: Preoperative medical images acquisition: CTA will be performed using a 16-slice unit (150 mAs, 110 kVp; acquisition thickness 5 mm, pitch 1.5; reconstruction thickness 1.2 mm), before and after intravenous administration of 100 mL of iodinated contrast material. MRI will be performed using a 1.5-T unit with 40-mT/m gradient power (Magneton Sonata Maestro Class, Siemens, Erlangen, Germany) and a four-channel cardio-thoracic coil. ECG-triggered, free-breathing through plane, and in-plane pc-MRI sequences will be performed for phase-velocity mapping of aortic and branches flow with the following technical parameters: TR/TE = 4/3.2 ms, thickness 5 mm, velocity encoding from 150 to 350 ms, and temporal resolution 41 ms.

Medical images processing: Ad hoc processing of preoperative CTAs, based on 3D multiplanar reconstruction, will be performed with 3Mensio Vascular software 8.0® (3Mensio Medical Imaging B.V.), which provides specific functions for automatic measurements. Patients will be stratified according to Aortic Arches Classification (AAC). Radius of curvature, PLZs angulation (tangent angle function) and tortuosity (tortuosity angle function) will be calculated. 3D segmentation of CTA, aimed for in-silico simulation purposes, will be performed by the software Mimics v18.0 (Materialise, Belgium). The 3D model of the aortic lumen in stl format will be used to create CFD suitable computational domain, called mesh by vmtk toolkit (www.vmtk.org). In-silico simulations: State-of-the-art CFD simulations for aortic hemodynamics will be performed by the CFD solver developed by the project EmPaTHIC (Emory Pavia Testing Hemodynamics) that updates LifeV Application Blood Flow through the collaboration among Emory University, Atlanta,Georgia,USA (Prof. A. Veneziani) and University of Pavia (UniPV) (Prof. F. Auricchio). The analysis will run on the cluster available at UniPV Nume-Lab. The project foresees to increase the computational power by adding another node to the available UniPV cluster and also the set-up of a server at Policlinico San Donato (PSD) dedicated to data storage and visualization of the results. Computation of drag forces: The post-processing of the simulations will be performed by python-scripts based on Visualization Toolkit (VTK) libraries and ParaView software (Kitware® Inc., France). Such an analysis aims at computing semi-automatically the aortic centerline, splitting the aortic arch in four regions (i.e., landing zones), and calculating the magnitude and direction of the drag forces in each zone, through the whole cardiac cycle. Preliminary analysis will be performed to assess if the systolic peak is the most relevant time instant for our purposes, in order to possibly reduce the post-processing efforts.

Experimental Design Aim 2: Medical images acquisition: The pre-operative images acquired for Aim 1 will be used. Medical images processing: The 3D models of the aortic lumen derived from the processing performed for Aim 1 will be used. In-silico simulations, Two types of analysis will be performed: 1) Simulation of TEVAR by FEA to predict endograft apposition; 2) CFD analysis to compute post-TEVAR hemodynamics. These simulations will be performed in a serial manner defining a computational framework, which is already developed and tested. FEA of TEVAR: As previously reported by our Group, the geometrical models of the implanted endografts resemble the main features of real endografts samples; mechanical properties are derived from available literature. ABAQUSv16 (Simulia, Dassault Systèmes®, FR) is used as FEA solver. CFD for post- TEVAR hemodynamics: Starting from the configuration of the endograft predicted by the FEA, the computational domain, resembling the aorta with the endovascular implant, is build using image-distance technique. The analysis is then run as described in Aim 1. Computation of drag forces: As described in Aim 1, the developed post-processing tool will be used to compute the magnitude and direction of the drag forces along the arch, and also on the inner surface of the deployed endograft.

Experimental Design Aim 3: Postoperative medical images acquisition: CTA and MRI studies and ad-hoc analysis of the images will be performed at 6-month follow-up in recruited patients as described in Aim 1. In-silico simulations: CFD analyses will be performed as described in Aim

  1. Medical images processing: The same approach and the same tools proposed in Aim 1 will be used. Segmentation of post-operative CTA will be performed to reconstruct a 3D model of the aortic lumen and of the struts of the deployed endografts. Computation of drag forces and validation: As in Aim 1, 3D segmentation of post-operative CTA combined with flow data from pc-MRI will be used to run CFD analysis in order to: 1) Assess the predictive value of the drag forces measured preoperatively (Aim 1); 2) Validate the results from in-silico simulations (Aim 2).

Study Design

Study Type:
Observational
Anticipated Enrollment :
45 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Mapping of Aortic Arch Hemodynamics by Biomechanical Analysis and Modeling for Planning Thoracic Endovascular Aortic Repair
Actual Study Start Date :
May 23, 2019
Anticipated Primary Completion Date :
Jan 30, 2022
Anticipated Study Completion Date :
Jan 30, 2022

Arms and Interventions

Arm Intervention/Treatment
TEVAR patients

patients scheduled for thoracic endovascular aortic repair

Diagnostic Test: TEVAR patients
Computed Tomography Angiography (CTA) will be performed using a 16-slice unit before and after intravenous administration of 100 mL of iodinated contrast material. Phase contrast-Magnetic Resonance (pc-MRI) will be performed using a 1.5-T unit with 40-mT/m gradient power and a four-channel cardio-thoracic coil. ECG-triggered, free-breathing through plane, and in-plane pc-MRI sequences will be performed for phase-velocity mapping of aortic and branches flow. Ad hoc processing of preoperative CTAs, based on 3D multiplanar reconstruction, will be performed with 3Mensio Vascular software 8.0® (3Mensio Medical Imaging B.V.), which provides specific functions for automatic measurements.
Other Names:
  • CTA and pc-MRI
  • Outcome Measures

    Primary Outcome Measures

    1. Displacement Force [magnitude (N)] [18 months]

      Comparison among the Type of Arch (TOA); Comparison among pre- and post-Thoracic Endovascular Aortic Repair (TEVAR)

    2. Displacement Force [Vector (-)] [18 months]

      Comparison among the Type of Arch (TOA); Comparison among pre- and post-Thoracic Endovascular Aortic Repair (TEVAR)

    Secondary Outcome Measures

    1. Area of proximal landing zones (PLZs) (mm2) [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    2. Equivalent Surface Traction (EST) (N/ mm2) [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    3. Radius of curvature (1/mm) [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    4. Angulation (tangent angle function) [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    5. Tortuosity (tortuosity angle function) [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    6. Mean and maximum flow velocity magnitude (cm/sec) in aortic along the cardiac cycle [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    7. Systolic wall shear stress (dyn/cm2) [18 months]

      Comparison among the TOA and PLZs

    8. Time-averaged wall shear stress (TAWSS) (dyn/cm2) [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    9. Oscillatory index (OSI) (%) [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    10. Flow helicity [18 months]

      Comparison among the TOA and PLZs; Comparison among pre- and post-TEVAR

    11. Aortic inflow (L/min) [18 months]

      Comparison among the TOA; Comparison among pre- and post-TEVAR

    12. Aortic flow split (%) [18 months]

      Comparison among the TOA; Comparison among pre- and post-TEVAR

    13. Brachial arterial pressure (mmHg) [18 months]

      Comparison among the TOA; Comparison among pre- and post-TEVAR

    14. Mean and maximum arterial pressure (mmHg) [18 months]

      Comparison among the TOA; Comparison among pre- and post-TEVAR

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age over 18 years old

    • Must be able to give Informed Consent

    • Must to be enrolled at the Surgery Unit of one of the recruitment centres with chronic thoracic aortic pathologies (including atherosclerotic and post-dissection aneurysms, and penetrating ulcer/intramural hematoma)

    • Must to be scheduled for elective TEVAR with surgical supra-aortic vessel (SAV) debranching (established and performed according to Guidelines)

    Exclusion Criteria:
    • Patients with previous aortic surgical or endovascular procedures

    • General contraindications to MRI or CT studies

    • Suspected or manifested pregnancy

    • Systemic diseases judged non-compatible with the procedures

    • Any incapability to give informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IRCCS Policlinico San Donato San Donato Milanese Milan Italy 20097

    Sponsors and Collaborators

    • Ospedale San Donato
    • University of Pavia

    Investigators

    • Principal Investigator: Massimiliano M Marrocco-Trischitta, MD,PhD, Ospedale San Donato

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Massimiliano M. Marrocco-Trischitta, Vascular Surgeon, Principal Investigator, Doctor of Medicine and of Philosophy, Ospedale San Donato
    ClinicalTrials.gov Identifier:
    NCT03824626
    Other Study ID Numbers:
    • 160/int/2017
    First Posted:
    Jan 31, 2019
    Last Update Posted:
    Oct 22, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Massimiliano M. Marrocco-Trischitta, Vascular Surgeon, Principal Investigator, Doctor of Medicine and of Philosophy, Ospedale San Donato
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 22, 2020